FORM 20-F Grupo Casa Saba, S.A.B. de C.V.
FORM 20-F Grupo Casa Saba, S.A.B. de C.V.
FORM 20-F Grupo Casa Saba, S.A.B. de C.V.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Table of Contents<br />
We distribute these products throughout Mexico through our nationwi<strong>de</strong> distribution network to customers in the following segments:<br />
●<br />
●<br />
●<br />
●<br />
●<br />
●<br />
approximately 14,000 pharmacies owned by private individuals;<br />
over 5,100 privately-owned pharmacy chains and around 6<strong>20</strong> government pharmacies;<br />
approximately 3,500 regional and national supermarkets;<br />
approximately 600 racks and 110 nationwi<strong>de</strong> agents;<br />
over 160 <strong>de</strong>partment stores; and<br />
approximately 330 major wholesalers and 3,100 convenience stores.<br />
In addition, we are also one of the largest pharmacy retailers in Latin America, where in <strong>20</strong>11 we operated over 900 pharmacies in 19 Mexican states, and the<br />
metropolitan area of Mexico City, more than 350 pharmacies throughout Chile and more than 85 pharmacies in the states of Rio <strong>de</strong> Janeiro and São Paulo in Brazil through which we sell<br />
pharmaceutical products as well as health and beauty aids and other related consumer goods.<br />
Our consolidated net sales for the year en<strong>de</strong>d on December 31, <strong>20</strong>11 totaled Ps. 46,568.2 million, approximately 78% of which were ma<strong>de</strong> in Mexico. As of the end of<br />
<strong>20</strong>11, our total assets were Ps. 32,094,059 million and we owned 22 distribution centers in Mexico,one distribution center in Santiago, Chile and the Sports Clinic facility in Tampico,<br />
Tamaulipas. Our operations outsi<strong>de</strong> of Mexico represented 22% of our consolidated net sales for the year en<strong>de</strong>d on December 31, <strong>20</strong>11.<br />
Our operations are currently organized into five operative business divisions: the Private Pharmaceutical Products business division, which we refer to as “Private<br />
Pharma” (46.16% of our consolidated net sales in <strong>20</strong>11); the “Retail Pharmacy” Division which inclu<strong>de</strong>s results from our retail pharmacies business (44.34% of our consolidated nets<br />
sales in <strong>20</strong>11); the Government Pharmaceutical business division, which we refer to as “Government Pharma” (2.60% of our consolidated net sales in <strong>20</strong>11); the Health, Beauty Aids,<br />
Consumer Goods, General Merchandise and Other Products business division, which we refer to as the “HBCG/Other Products” business division (5.<strong>20</strong>% of our consolidated net sales<br />
in <strong>20</strong>11); and the Publications business division (1.70% of our consolidated net sales in <strong>20</strong>11). The following table shows our sales by business division, as a percentage of<br />
consolidated net sales for the last three years:<br />
Year En<strong>de</strong>d December 31,<br />
<strong>20</strong>09 <strong>20</strong>10 <strong>20</strong>11<br />
Pharmaceuticals(1)(2):<br />
- Private 75.11% 71.91% 46.16%<br />
- Government 3.04% 2.83% 2.60%<br />
Health, Beauty, Consumer Goods, General Merchandise & Other Products 8.49% 6.42% 5.<strong>20</strong>%<br />
Publications 2.53% 2.47% 1.70%<br />
Retail Pharmacy 10.82% 16.36% 44.34%<br />
Total 100% 100% 100%<br />
_________________<br />
(1) For a brief <strong>de</strong>scription of the types of products inclu<strong>de</strong>d within the term “pharmaceutical products” for purposes of this annual report, as well as a discussion<br />
of the differences between the pharmaceutical markets in Mexico and the United States, see “—Pharmaceutical Industry,” below in this item.<br />
(2) In <strong>20</strong>09, the operations of <strong>Casa</strong> <strong>Saba</strong> Brasil and our retail pharmacy business in Mexico were consolidated and reflected in the Private Pharmaceuticals<br />
business division. For the year en<strong>de</strong>d December 31, <strong>20</strong>10 and thereafter the results of our retail pharmacy business will be reported separately as the “Retail<br />
Pharmacy-” division.<br />
30